In what circumstance would you consider stopping tisotumab-vedotin after a complete response for a patient with recurrent/persistent cervical cancer?
Community PollStarted
If a patient has a complete response to tisotumab vedotin for recurrent cervical cancer, what would you recommend?
16 physicians have voted
Join Mednetto vote and see how they answered.